Product Images Irbesartan And Hydrochlorothiazide

This appears to be a blood pressure chart with the goal of having a systolic blood pressure (SBP) reading below 140 mmHg. There are also references to studies involving HCTZ (hydrochlorothiazide) and irbe (irbesartan) for potentially lowering blood pressure.*

This appears to be a graph displaying blood pressure readings in millimeters of mercury (mmHg), with the x-axis representing baseline SBP (systolic blood pressure) and the y-axis displaying measurement in mmHg. The only written text is a guideline denoting that an SBP below 130 mmHg is desirable.*

This appears to be a list of study names, and a baseline of diastolic blood pressure readings in mmHg. There is not enough information to determine what type of studies these are or what they are related to.*

This appears to be a table or chart displaying various studies (irbe/HCTZ Study V, Irb. Study V, HCTZ Study V, irbe/HCTZ Study VI, and Irb. Study VI) and their corresponding baseline DBP values in mmHg. Without further context, it's difficult to determine the purpose or significance of these studies and values.*

The text mentions information about a tablet that includes the ingredients irbesartan-hydrochloride. The manufacturer of the product is Winthrop U.S. and it is a business of sanofi-aventis U.S. LLC located in Bridgewater. The package can be stored within a temperature range of 15°-30°C. There is some unreadable text in the output, and therefore the information provided is incomplete.*

Each tablet of Irbesartan-hydrochlorothiazide contains 300/12.5 mg. For dosing information, refer to the package insert. The tablet should be stored between 15°C-30°C (59°F-86°F). The manufacturer, Winthrop U.S., is a Sanofi company based in Bridgewater, NJ 08807.*